Telangiectatic osteogenic sarcoma: a clinicopathologic study of 124 patients

Area of Science:

• Orthopedic Oncology
• Skeletal Radiology
• Surgical Pathology

Background:

• Telangiectatic osteogenic sarcoma is a rare variant of osteosarcoma, comprising 11% of cases.
• Lesions are typically lytic and destructive, with cystic and soft gross characteristics.
• Histological findings include dilated vascular spaces lined by sarcoma cells producing osteoid.

Purpose of the Study:

• To characterize telangiectatic osteogenic sarcoma.
• To compare its radiographic and histologic features with benign mimics.
• To evaluate survival rates and treatment efficacy.

Main Methods:

• Retrospective review of 124 patients treated at Memorial Sloan-Kettering Cancer Center (1921-1979).
• Analysis of radiographic, gross, and histologic findings.
• Comparison of survival rates based on lesion characteristics and treatment modalities.

Main Results:

• Telangiectatic osteogenic sarcoma frequently occurs in the femoral diaphysis and distal femur.
• Twenty-nine percent of patients experienced pathologic fractures.
• No significant survival differences were observed between purely lytic lesions versus those with minimal sclerosis, or between telangiectatic and ordinary osteosarcoma.
• A significant increase in survival was noted for patients treated since 1975 with preoperative multidrug chemotherapy.

Conclusions:

• Telangiectatic osteogenic sarcoma presents unique diagnostic challenges, requiring differentiation from benign bone lesions.
• Treatment with modern multidrug chemotherapy, particularly since 1975, has improved patient survival.
• Further research into optimal treatment strategies for this rare osteosarcoma variant is warranted.